59 studies found for:    Blood Transfusion | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Blood Transfusion | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Transfusion of Prematures Trial
Conditions: Infant, Newborn, Diseases;   Infant, Extremely Low Birth Weight;   Infant, Small for Gestational Age;   Bronchopulmonary Dysplasia (BPD);   Anemia
Interventions: Procedure: Liberal Cell Transfusion;   Procedure: Restricted red cell transfusion
2 Recruiting Effect of Red Blood Cell Transfusion on Brain Metabolism in Patients With Subarachnoid Hemorrhage
Conditions: Subarachnoid Hemorrhage;   Vasospasm
Intervention: Biological: Red blood cell transfusion
3 Recruiting Microparticles in Stored RBC as Potential Mediators of Transfusion Complications
Condition: Coronary Artery Bypass Graft Surgery
Interventions: Biological: Washed RBC;   Biological: Unwashed RBC
4 Unknown  Effects of Transfusion of Older Red Blood Cells on Patients With Hemoglobinopathies
Conditions: Sickle Cell Disease;   Thalassemia
Intervention: Biological: Transfusion
5 Unknown  Frozen Red Blood Cell Transfusions in Trauma Patients
Condition: Transfusion
Intervention: Biological: Red Blood Cells
6 Recruiting Study of Transfusion-Transmitted Infections
Condition: Virus Disease
Intervention:
7 Recruiting Optimized Erythropoietin (EPO) Treatment
Condition: Neonatal Anemia
Interventions: Drug: Epoetin Alpha;   Drug: Biotinylated Red Blood Cells
8 Recruiting Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Alloimmune Platelet Refractoriness
Intervention: Drug: Eculizumab
9 Recruiting Improving White Blood Cell Collection From Healthy Donors
Conditions: Blood Donor;   Leukocyte Transfusion;   Granulocyte Colony-Stimulation Factor;   Blood Component Removal
Interventions: Drug: Filgrastim (G-CSF);   Drug: Dexamethasone
10 Recruiting TT-CMV Observational Birth Cohort Study
Condition: Cytomegalovirus Disease
Intervention:
11 Unknown  Simplified Severe Sepsis Protocol-2 (SSSP-2) in Zambia
Conditions: Sepsis;   Severe Sepsis;   Tuberculosis
Interventions: Other: Simplified severe sepsis protocol;   Other: Usual care
12 Recruiting Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets
Condition: Thrombocytopenia
Interventions: Biological: CPP;   Biological: LSP
13 Not yet recruiting Topical TXA in Spine Trauma Surgery
Conditions: Spinal Injuries;   Spinal Deformity
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
14 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
15 Unknown  Simplified Severe Sepsis Protocol in Zambia
Conditions: Sepsis;   Severe Sepsis
Intervention: Other: Simplified Severe Sepsis Protocol
16 Recruiting Establishment of a Perinatal Database and a Bank of Biological Materials
Conditions: Preterm Labor;   Preterm Birth;   Pregnancy
Intervention:
17 Recruiting Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle Cell Disease and Beta-Thalassemia
Conditions: Peripheral Blood Stem Cell Transplantation;   Anemia, Sickle Cell;   Graft-Versus-Host Disease;   Sirolimus (Rapamune );   Alemtuzumab (Campath )
Interventions: Procedure: PBMC Transplant;   Drug: Alemtuzumab (Campath  );   Drug: Sirolimus (Rapamune  );   Drug: Cyclophosphamide (Cytoxan  );   Procedure: Low Dose Irradiation
18 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
19 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
Intervention:
20 Recruiting Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndrome;   Previously Treated Myelodysplastic Syndrome
Interventions: Biological: Epoetin Alfa;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years